Harness Advanced Computational Biology & Machine Learning to Transform Biologics Drug Discovery and Development
October 22-24, 2024 | Boston, MA
Welcome to the 9th CDD for Biologics Summit
For the past eight years, the CDD for Biologics Summit has united computational and structural biologists, along with protein and antibody engineers, to showcase emerging computational tools and models that are revolutionizing biologics drug discovery and development.
This summit has become an indispensable platform for industry leaders to collaborate, innovate, and drive drug discovery forward, with a focus on computational methods that enhance predictability, optimize molecular design, and streamline development processes. By integrating sophisticated modeling, data collection, and analysis techniques, participants will explore how to improve accuracy, reduce risks, and accelerate drug development timelines.
The 9th annual event returns to Boston in 2024, continuing to support drug developers of all sizes in advancing their biotherapeutics discovery and development. Join us to dive into the latest industry innovations, highlighting methods and best practices to automate and streamline data collection, integrate experimental data, and leverage cutting-edge computational tools for the progression of novel, complex biologics pipelines.
Expert Speaker Faculty Includes:
2024 Sponsors:
*Limited Availability for Sponsorship Places*
Hear What Previous Attendees Have to Say:
“This meeting will provide me with an opportunity to be updated with the latest work in the field and meet like-minded people to discuss science”
“By fostering an environment of open communication and collaboration, these conferences provide a platform for the exchange of ideas and best practices, enabling the community to grow and thrive”
“I see immense value in attending the Annual CDD for Biologics Summit. This event provides a unique opportunity to stay abreast of cutting-edge computational methods and best practices in biologics research”
“CDD provides an opportunity to go beyond the hype of AI/ML and discuss with other practitioners in the field the details of what the technology can do today”
Companies Who Have Confirmed Their Attendance:
